Nakao M - Search Results

1

Graft-versus-host disease confined solely to intestine after allogeneic peripheral blood stem cells transplantation in a patient with chronic myelogenous leukemia.

Nomura K, Nakao M, Matsumoto Y, Taji S, Yoshida N, Mitsufuji S, Yokota S, Horiike S, Okanoue T, Taniwaki M. Nomura K, et al. Among authors: nakao m. Hematology. 2004 Apr;9(2):131-3. doi: 10.1080/1024533042000205469. Hematology. 2004. PMID: 15203868 Free article.

2

Long-term molecular remission after nonmyeloablative stem cell transplantation in a patient with chronic myelogenous leukemia in the chronic phase.

Matsumoto Y, Nomura K, Shimizu D, Takeshima Y, Ueda K, Nakao M, Morita M, Yokota S, Horiike S, Taniwaki M. Matsumoto Y, et al. Among authors: nakao m. Acta Haematol. 2004;112(4):225-6. doi: 10.1159/000081279. Acta Haematol. 2004. PMID: 15564738 No abstract available.

3

Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma.

Matsumoto Y, Nomura K, Kanda-Akano Y, Fujita Y, Nakao M, Ueda K, Horiike S, Yokota S, Kusuzaki K, Kitoh T, Watanabe A, Taniwaki M. Matsumoto Y, et al. Among authors: nakao m. Leuk Lymphoma. 2003 May;44(5):879-82. doi: 10.1080/1042819031000067873. Leuk Lymphoma. 2003. PMID: 12802930

4

Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome.

Horiike S, Kita-Sasai Y, Nakao M, Taniwaki M. Horiike S, et al. Among authors: nakao m. Leuk Lymphoma. 2003 Jun;44(6):915-22. doi: 10.1080/1042819031000067620. Leuk Lymphoma. 2003. PMID: 12854888 Review.

5

Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections.

Matsumoto Y, Nomura K, Matsumoto S, Ueda K, Nakao M, Nishida K, Sakabe H, Yokota S, Horiike S, Nakamine H, Nakamura S, Taniwaki M. Matsumoto Y, et al. Among authors: nakao m. Cancer Genet Cytogenet. 2004 Apr 1;150(1):22-6. doi: 10.1016/j.cancergencyto.2003.08.008. Cancer Genet Cytogenet. 2004. PMID: 15041219

6

Intravascular B-cell lymphoma with hypercalcemia as the initial presentation.

Chinen Y, Nakao M, Sugitani-Yamamoto M, Kiyota M, Horiike S, Kuroda J, Taniwaki M. Chinen Y, et al. Among authors: nakao m. Int J Hematol. 2011 Dec;94(6):567-70. doi: 10.1007/s12185-011-0959-8. Epub 2011 Nov 3. Int J Hematol. 2011. PMID: 22045306

7

The response to second-line induction with bortezomib and dexamethasone is predictive of long-term outcomes prior to high-dose chemotherapy with autologous stem cell transplantation for multiple myeloma.

Kobayashi T, Kuroda J, Fuchida S, Murakami S, Hatsuse M, Okano A, Iwai T, Tsutsumi Y, Kamitsuji Y, Akaogi T, Kawata-Iida E, Shimizu D, Uchiyama H, Matsumoto Y, Horiike S, Nakao M, Takahashi R, Kaneko H, Uoshima N, Kobayashi Y, Shimazaki C, Taniwaki M. Kobayashi T, et al. Among authors: nakao m. Intern Med. 2013;52(9):961-8. doi: 10.2169/internalmedicine.52.9385. Epub 2012 Mar 1. Intern Med. 2013. PMID: 23648714 Free article.

8

Differentiation of follicular from mucosa-associated lymphoid tissue lymphoma by detection of t(14;18) on single-cell preparations and paraffin-embedded sections.

Nomura K, Sekoguchi S, Ueda K, Nakao M, Akano Y, Fujita Y, Yamashita Y, Horiike S, Nishida K, Nakamura S, Taniwaki M. Nomura K, et al. Among authors: nakao m. Genes Chromosomes Cancer. 2002 Feb;33(2):213-6. doi: 10.1002/gcc.10013. Genes Chromosomes Cancer. 2002. PMID: 11793448

9

Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.

Nakao M, Horiike S, Fukushima-Nakase Y, Nishimura M, Fujita Y, Taniwaki M, Okuda T. Nakao M, et al. Br J Haematol. 2004 Jun;125(6):709-19. doi: 10.1111/j.1365-2141.2004.04966.x. Br J Haematol. 2004. PMID: 15180860 Free article.

10

Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study.

Matsumoto Y, Kobayashi T, Shimura Y, Kawata E, Nagoshi H, Ohshiro M, Sugitani M, Shimura K, Iwai T, Fuchida SI, Yoshida M, Kiyota M, Mizutani S, Chinen Y, Takimoto-Shimomura T, Nakao M, Kaneko H, Uchiyama H, Uoshima N, Nishigaki H, Kobayashi Y, Horiike S, Shimazaki C, Taniwaki M, Kuroda J; Kyoto Clinical Hematology Study Group (KOTOSG). Matsumoto Y, et al. Among authors: nakao m. Int J Hematol. 2019 Jul;110(1):77-85. doi: 10.1007/s12185-019-02650-w. Epub 2019 May 24. Int J Hematol. 2019. PMID: 31127456 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,297 results

Search Page

Filters